Skip to content
Market Spectator

Market Spectator

Primary Menu
  • Business
  • Domestic
  • Economy
  • Politics
  • Top News
  • Newsletters
Live
  • Home
  • 2026
  • November
  • 17
  • Lowe’s Reports Tomorrow. The Stock Is 27% Off Its Low.
  • Money

Lowe’s Reports Tomorrow. The Stock Is 27% Off Its Low.

Q3 earnings arrive Wednesday morning with options pricing a 5% move and a housing recovery still on the clock.
Market Spectator November 17, 2026 4 minutes read
830d540e-5ce2-4571-8954-419bf120eb64

Lowe’s Companies reports fiscal Q3 2026 earnings Wednesday, November 18, before the open. The stock has recovered about 27% from its October 5 low of $178.45. The question today is whether the results can justify that recovery, or confirm the skeptics who downgraded it last week.

Why This Stock Now

Options traders are pricing approximately a 5.14% move in either direction following tomorrow’s report. That is not a routine quarterly event. It is a referendum on whether Lowe’s Pro pivot, now the company’s primary growth engine, can sustain momentum into 2027 as the broader housing market remains effectively frozen. The answer to that question will determine whether the stock regains its prior trading range near $260 to $280 or stalls again at current levels around $226.

The Business

Lowe’s operates more than 1,750 stores and more than 540 branches across the United States. It is the second-largest home improvement retailer in North America. For most of its history, Lowe’s growth tracked housing turnover. When people bought homes, they spent on renovation. That correlation has become a liability in 2026, with mortgage rates elevated and housing turnover near multi-decade lows. So management pivoted.

The Pro segment, targeting professional contractors rather than do-it-yourself consumers, now drives what growth Lowe’s is generating. Pro customers typically spend more per transaction and visit more frequently than DIY buyers. CEO Marvin Ellison has expanded the Pro salesforce, deepened the MyLowe’s Pro Rewards loyalty program, and completed acquisitions pushing Lowe’s into professional and commercial distribution, which carries higher margins than retail.

Why Wall Street Is Paying Attention

The stock is down approximately 5% year-to-date and about 23% from its 52-week high of $293.06, reached on February 12, 2026, before the housing slowdown deepened. At roughly $226, it trades at about 18 times trailing earnings and about 17 to 18 times forward earnings.

Lowe’s has beaten earnings estimates in each of its last eight consecutive quarters. Last quarter, it delivered EPS of $4.40 against a $4.22 estimate, with revenue up 8.3% year-over-year. That track record of bottom-line execution despite top-line headwinds is what separates the case from pure housing cyclicality. The company is not just waiting for a recovery. It is building a Pro business designed to outperform regardless.

Consensus for tomorrow calls for EPS around $2.87. Guidance, however, matters more than the quarter. When Lowe’s cut its full-year outlook in August, the stock fell. What management says about Q4 and 2027 will drive the stock more than what happened in August and September.

What’s Driving the Opportunity

Three structural tailwinds underpin the medium-term case. The U.S. housing stock is the oldest on record. Homeowners living in their current homes for the longest duration in modern history are still replacing roofs, HVAC systems, and plumbing regardless of whether they are moving. That maintenance cycle is durable.

Pro contractor backlogs have remained healthy even with DIY weakness. As Lowe’s deepens wallet share with small and medium Pro customers through digital tools and exclusive financing, it is capturing recurring revenue that did not exist in its model five years ago. And when mortgage rates eventually ease, the company is better positioned to benefit than it has been in its recent history, with a refreshed Pro channel and an expanded store count.

What Could Go Wrong

Stifel downgraded Lowe’s to Sell last week ahead of tomorrow’s report, citing housing market weakness, margin pressure in fiscal 2027 and 2028, and increased competition. Home Depot, with its deeper Pro penetration and larger commercial accounts, continues to outperform Lowe’s in the segment Lowe’s is explicitly trying to win. If Pro comps disappoint tomorrow, there is no other growth story to tell.

A guidance cut would be the worst outcome, confirming that the stock’s October recovery was premature. The realistic timeline for a housing-driven comp acceleration runs into 2027 at the earliest, which means the stock needs the Pro segment to hold alone in the interim.

The Bottom Line

Lowe’s is not a slam-dunk at $226, but it is not the broken story its year-to-date performance implies. Eight straight earnings beats, a Pro pivot generating real traction, an oldest-on-record housing stock that needs constant maintenance, and a 2.2% dividend yield from a company that has raised its payout for decades make for a credible recovery thesis. Tomorrow’s report is the next data point. Guidance on Pro momentum and 2027 comps will tell investors whether the October low was a bottom or just a stop on the way down.

Post navigation

Previous: Roche Gets an FDA Approval for a Rare Kidney Disease
Next: Good News From American Consumers Could Hurt Stocks Today

Related Stories

812ff6f2-7788-4db6-8e63-5fd9858563ca
  • Money

Allianz Raised Its 2026 Profit Target to €18.6bn. PIMCO Drove the Beat.

Market Spectator November 12, 2026
990ed45e-7415-4bc4-8dfb-fa1228770cb2
  • Money

Lyft’s Hidden Asset Is Worth More Than Its Stock Price

Market Spectator November 11, 2026
5948baff-b97a-4a07-8a8d-d4229736405a
  • Money

Google Owns the Wyoming Campus It Once Would Have Rented. What Does That Cost CoreWeave?

Market Spectator November 9, 2026

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

  • Good News From American Consumers Could Hurt Stocks Today
  • Lowe’s Reports Tomorrow. The Stock Is 27% Off Its Low.
  • Roche Gets an FDA Approval for a Rare Kidney Disease
  • Brent Fell After Iran Hit Bahrain. That Tells You Everything.
  • Brent Fell After Iran Hit Bahrain. That Tells You Everything.
  • Tesla’s $29,990 Cybercab Has a $299 Monthly Fee
  • Tesla Is Selling You a Driverless Car. The Bill Is the Story.

Categories

  • Business
  • Economy
  • Money
  • Newsletters
  • Politics
  • Top News

You may have missed

56e5c18c-a867-4581-923b-4d71ffc87e28
  • Newsletters

Good News From American Consumers Could Hurt Stocks Today

Market Spectator November 17, 2026
830d540e-5ce2-4571-8954-419bf120eb64
  • Money

Lowe’s Reports Tomorrow. The Stock Is 27% Off Its Low.

Market Spectator November 17, 2026
928de7d2-8897-404a-9cfe-6ef8449e1e31
  • Politics

Roche Gets an FDA Approval for a Rare Kidney Disease

Market Spectator November 16, 2026
f50c7cf9-872f-4490-b046-7e8763550f40-1
  • Newsletters

Brent Fell After Iran Hit Bahrain. That Tells You Everything.

Market Spectator November 16, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service/Use Agreement
  • Contact Us
Copyright 2026 © All rights reserved | Market Spectator | marketspectator.com SITE_OK